Improved quantification of neutrophil activity in serum is achieved by measuring calprotectin metabolites
A novel serum calprotectin assay (CPa9-HNE) has been developed, which quantifies neutrophil activity and correlates with disease activity in patients with Crohn’s disease and ulcerative colitis.